You are here » Home » Companies » Company Overview » Transgene Biotek Ltd

Transgene Biotek Ltd.

BSE: 526139 Sector: Health care
NSE: N.A. ISIN Code: INE773D01018
BSE 00:00 | 20 Mar 3.92 0.07
(1.82%)
OPEN

3.85

HIGH

3.92

LOW

3.85

NSE 05:30 | 01 Jan Transgene Biotek Ltd
OPEN 3.85
PREVIOUS CLOSE 3.85
VOLUME 14203
52-Week high 6.08
52-Week low 1.81
P/E
Mkt Cap.(Rs cr) 30
Buy Price 3.90
Buy Qty 200.00
Sell Price 3.92
Sell Qty 3809.00
OPEN 3.85
CLOSE 3.85
VOLUME 14203
52-Week high 6.08
52-Week low 1.81
P/E
Mkt Cap.(Rs cr) 30
Buy Price 3.90
Buy Qty 200.00
Sell Price 3.92
Sell Qty 3809.00

Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Company History

Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90. The company is engaged in the research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively. Transgene Biotek's products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial Area,Bollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.